Connect with us

Featured

Why are Indian Pharma Companies and Medicines in High Demand in China?

Published

on

What makes the Indian Pharma Companies Globally Attractive? India is taking long strides to emerge as a global superpower in pharmacy. The pharmaceutical industry in India now has a great demand even in the restricted Chinese market. The cases of Indian medicines being smuggled in China are very common now. The cost-effective medicines made in India seems to be attracting many international markets, including China

Other News at EurAsian Times

China is expected to expand imports of medicines of Indian origin in the wake of improving bilateral relations. It is time for the Indian pharmaceutical industry to envelope the Chinese market. India accounts for 10% of the global pharmaceutical industry. In the fiscal year 2017, a revenue of $ 30 billion is evident of India’s grasp over the international market. It is a perfect opportunity for India to embrace not only the Chinese market but the international market a well. India is the largest producer of generic medicines globally and accounts for 20% of the global market for generic medicines.

What makes India ‘The Pharmacy of the World?

The pharmaceutical industry in India rides on cost-effectiveness. There are many advantages it offers. Indian pharmaceutical industry enjoys economical land, labour, equipment and other utilities. As compared to the west, production line in India is around 40% cheaper. Additionally, the labour costs in India is around 50% cheaper than the west. The policies of the Indian government and the laid down laws also encourage the Indian pharmaceutical industry.

Why Pharma Companies in India Must Eye the Chinese Market?

Smuggling of Indian drugs and an underground market in China are evident in high demand. Certainly, there’s high demand for low-cost medicines in China for cancer and other diseases. Despite high demand and the growth of pharmaceutical industry in India, Indian medicines are rarely seen in the Chinese market.

However, in May this year, China removed tariff from 28 drugs. These primarily include those essential for the treatment of cancer. Now the Indian pharmaceutical industry must look to benefit from this move. The people of China would have an alternative now and that would be available at much lower costs.

Surprisingly this win-win scenario hasn’t attracted many Indian companies. Indian pharmaceutical companies are happy to play the waiting game. They are primarily concerned about the fact that the field test and approval procedures would be too long. Hence they have adopted a wait and see stance.

The Difference in Regulatory Norms 

The regulatory norms for drugs in India and China are different. India has a regulatory system borrowed from the US and UK. China’s regulatory system is that of great deliberation and cautiousness. However, China is working on easing the norms. The changes have been instigated.  Once the Chinese regulatory system becomes friendly for the pharmaceutical industry in India, Delhi must look to win the Chinese market.

Read More at EurAsian Times

Advertisement
Advertisement

Facebook

FEATURED

F-35-INDIA F-35-INDIA
Americas5 hours ago

Not F-35 Jets or F-22 Raptors, This is The World’s 1st Stealth Aircraft & Still The Fastest Ever

The United States along with Russia are front-runners when it comes to devising modern technology and blending it with state-of-the-art...

INDIA-CHINA INDIA-CHINA
Asia Pacific7 hours ago

China Could Soon Deploy ‘Unmanned Helicopters’ In Ladakh As Tensions Mount With India

With the diplomatic and military talks in progress between the high ranking officials of New Delhi and Beijing, Indian and...

Capital-of-Israel-Jerusalem Capital-of-Israel-Jerusalem
Featured8 hours ago

Three Islamic Countries That May Never Recognize Israel Despite The Acceptance Of Saudi Arabia?

In the wake of the ongoing developments, when clouds of war are hovering over India and China / Pakistan, perhaps...

missile missile
Featured9 hours ago

Russian & Israeli Origin Missiles Deployed In Ladakh As India Looks To Keep China At Bay

Amid heightening tensions in Eastern Ladakh with China, India has reportedly deployed BrahMos and Nirbhay cruise missiles along with Akash...

C-17-GLOBEMASTER C-17-GLOBEMASTER
Expert Reviews10 hours ago

Not Rafale Jets, But C-17 Globemasters Will Be The Real ‘Game Changer’ In India-China Clash At Ladakh

With neither of the two neighbours India or China ready to put their sword down, Ladakh continues to become a...

BALOCHISTAN BALOCHISTAN
Featured15 hours ago

Afghan Peace Talks: Afghanistan’s Chief Peace Negotiator Lands In Pakistan

Afghan Peace Talks: Abdullah Abdullah will meet Pakistan’s President Arif Alvi, Prime Minister Imran Khan, Foreign Minister Shah Mehmood Qureshi,...

INDIAN-NAVY INDIAN-NAVY
Expert Reviews16 hours ago

Three Regions Where India Is Silently ‘Choking’ China & A Furious Beijing Has No Answer?

While China is finding itself getting entangled in serious standoffs with several countries including India and the US, it is...

LASER-WEAPONS LASER-WEAPONS
Americas18 hours ago

DRDO Accelerates Work On ‘Laser Weapons’; But Where Does India Stand Against China, Russia & The US?

There might be a possibility that future global conflicts including between India and China could be fought with Star Wars-type...

turkey-Pakistan-ties turkey-Pakistan-ties
EurAsian Region19 hours ago

Turkey, Pakistan Vow Full Support To Azerbaijan Against Armenia; US, Iran Call For De-Escalation

The Middle East and Asian nations expressed their concern over escalating clashes between Armenian forces and Azerbaijani military in the...

F-35-INDIA F-35-INDIA
Americas1 day ago

Massive Loophole Detected In ‘Stealth’ F-35 Fighter Jets; Exposes The Limitations Of The Mighty F-35s

The Lockheed Martin F-35 Lightning II is a single-seat, single-engine, all-weather stealth multirole combat aircraft designed to perform both air...

Advertisement